Why is Aristo Bio-Tech falling/rising?

As of 29-Jul, Aristo Bio-Tech & Lifescience Ltd is experiencing a decline in its stock price, currently at 120.00, which reflects a decrease of 1.1 or 0.91%. The stock has underperformed its sector today by 2.94%, and it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a modest increase of 0.33%, but it has a year-to-date decline of 9.77%. Notably, there has been a rise in investor participation, with delivery volume increasing by 81.82% against the 5-day average, indicating some interest despite the overall downward movement. There is no information available regarding positive or negative factors that could have influenced the stock's recent performance. In the broader market context, the Sensex has declined by 0.96% over the past week, which suggests that the stock's short-term performance is slightly better than the benchmark. However, over the past month, while Aristo Bio-Tech has gained 6.62%, the Sensex has fallen by 3.19%, indicating that the stock has outperformed the market in this timeframe. Despite this, the year-to-date performance shows a stark contrast, with the stock down nearly 10% while the Sensex has increased by 4.97%, highlighting a challenging environment for Aristo Bio-Tech relative to the broader market.